Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Codexis Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CDXS
Nasdaq
8731
https://www.codexis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Codexis Inc
Codexis to Report First Quarter 2024 Financial Results on May 2
- Apr 18th, 2024 8:05 pm
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
- Apr 11th, 2024 11:05 am
Favourable Signals For Codexis: Numerous Insiders Acquired Stock
- Mar 30th, 2024 12:57 pm
Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:40 pm
Q4 2023 Codexis Inc Earnings Call
- Feb 29th, 2024 12:08 pm
Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates
- Feb 28th, 2024 11:50 pm
Codexis Inc (CDXS) Reports Fiscal Year 2023 Financial Results
- Feb 28th, 2024 9:59 pm
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Feb 28th, 2024 9:05 pm
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
- Feb 26th, 2024 9:05 pm
Codexis to Participate in TD Cowen 44th Annual Health Care Conference
- Feb 26th, 2024 1:05 pm
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
- Feb 20th, 2024 1:05 pm
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
- Feb 14th, 2024 9:05 pm
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones
- Feb 13th, 2024 9:05 pm
seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting
- Feb 1st, 2024 9:05 pm
The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable
- Jan 14th, 2024 1:01 pm
Baillie Gifford Trims Position in Codexis Inc
- Jan 9th, 2024 12:03 am
Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108
- Dec 27th, 2023 1:30 pm
Codexis, Inc. (NASDAQ:CDXS) Stock Rockets 41% But Many Are Still Ignoring The Company
- Dec 18th, 2023 11:13 am
Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?
- Dec 15th, 2023 11:00 am
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
- Dec 13th, 2023 9:06 pm
Scroll